Janssen Sues Sandoz Over Alzheimer's Drug Patent

Law360, New York (August 18, 2008, 12:00 AM EDT) -- Two Johnson & Johnson subsidiaries and their licensing partner have launched a patent infringement suit against Novartis AG’s generics arm, Sandoz Inc., after the generics maker filed an abbreviated new drug application for Razadyne, a drug used to treat Alzheimer's.

In a complaint filed Aug. 13 in the U.S. District Court for the District of Delaware, Janssen Pharmaceutica, Ortho-McNeil-Janssen Pharmaceuticals Inc. and Synaptech Inc. allege that Sandoz's ANDA falls within one or more claims of a patent pertaining to a method of treatment of Alzheimer’s....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.